论文部分内容阅读
作者用肝素-Ca~(2+)法对97名正常人、215例肝病患者的高密度脂蛋白胆固醇(HDL-ch)作了测定。其结果为,正常人61.89±10.74ng/dl、急性肝炎急性期患者27.94±6.18ms/dl、急性肝炎恢复期患者39.47±7.21mg/dl、慢性非活动性肝炎50.28±13.10mg/dl、慢性活动性肝炎41.73±12.53mg/dl、肝硬化代偿期45.04±11.49mg/dl、肝硬化失代偿期28.11±10.27mg/dl、肝癌23.89±11.34mg/dl。各实验组均显示低值,与正常组之间都有非常显著的差异。在慢性肝脏疾患时,HDL-ch值在25mg/dl以下者的预后均不良(在24例HDL-ch值低
The authors used a heparin-Ca 2+ method to determine HDL-c in 97 normal subjects and 215 patients with liver disease. The results were 61.89 ± 10.74ng / dl in normal subjects, 27.94 ± 6.18ms / dl in patients with acute acute hepatitis, 39.47 ± 7.21mg / dl in patients with acute hepatitis and 50.28 ± 13.10mg / dl in patients with chronic hepatitis, and chronic 41.73 ± 12.53mg / dl for active hepatitis, 45.04 ± 11.49mg / dl for decompensated liver cirrhosis, 28.11 ± 10.27mg / dl for decompensated liver cirrhosis and 23.89 ± 11.34mg / dl for liver cancer. Each experimental group showed a low value, there was a very significant difference between the normal group. In patients with chronic liver disease, those with a HDL-ch of 25 mg / dL or less have a poor prognosis (in 24 patients with low HDL-ch